International scientific guideline: Points to consider concerning endpoints in clinical studies with haematopoeitic growth factors for mobilisation of autologous stem cells

About this guideline

Overseas effective date: 19 April 2001

Categories: Clinical efficacy and safety | Blood and blood-forming organs

Access this international scientific guideline

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.